Literature DB >> 19920353

alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice.

Hiroyuki Nakayama1, Ilona Bodi, Robert N Correll, Xiongwen Chen, John Lorenz, Steven R Houser, Jeffrey Robbins, Arnold Schwartz, Jeffery D Molkentin.   

Abstract

In noncontractile cells, increases in intracellular Ca2+ concentration serve as a second messenger to signal proliferation, differentiation, metabolism, motility, and cell death. Many of these Ca2+-dependent regulatory processes operate in cardiomyocytes, although it remains unclear how Ca2+ serves as a second messenger given the high Ca2+ concentrations that control contraction. T-type Ca2+ channels are reexpressed in adult ventricular myocytes during pathologic hypertrophy, although their physiologic function remains unknown. Here we generated cardiac-specific transgenic mice with inducible expression of alpha1G, which generates Cav3.1 current, to investigate whether this type of Ca2+ influx mechanism regulates the cardiac hypertrophic response. Unexpectedly, alpha1G transgenic mice showed no cardiac pathology despite large increases in Ca2+ influx, and they were even partially resistant to pressure overload-, isoproterenol-, and exercise-induced cardiac hypertrophy. Conversely, alpha1G-/- mice displayed enhanced hypertrophic responses following pressure overload or isoproterenol infusion. Enhanced hypertrophy and disease in alpha1G-/- mice was rescued with the alpha1G transgene, demonstrating a myocyte-autonomous requirement of alpha1G for protection. Mechanistically, alpha1G interacted with NOS3, which augmented cGMP-dependent protein kinase type I activity in alpha1G transgenic hearts after pressure overload. Further, the anti-hypertrophic effect of alpha1G overexpression was abrogated by a NOS3 inhibitor and by crossing the mice onto the Nos3-/- background. Thus, cardiac alpha1G reexpression and its associated pool of T-type Ca2+ antagonize cardiac hypertrophy through a NOS3-dependent signaling mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920353      PMCID: PMC2786799          DOI: 10.1172/JCI39724

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

Review 1.  Caveolae and caveolins in the cardiovascular system.

Authors:  Jean-Philippe Gratton; Pascal Bernatchez; William C Sessa
Journal:  Circ Res       Date:  2004-06-11       Impact factor: 17.367

2.  Cell cycle--dependent expression of L- and T-type Ca2+ currents in rat aortic smooth muscle cells in primary culture.

Authors:  T Kuga; S Kobayashi; Y Hirakawa; H Kanaide; A Takeshita
Journal:  Circ Res       Date:  1996-07       Impact factor: 17.367

3.  Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.

Authors:  A Calderone; C M Thaik; N Takahashi; D L Chang; W S Colucci
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Diego Belardi; Shuxun Ren; E Rene Rodriguez; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

5.  Increases of T-type Ca2+ current in heart cells of the cardiomyopathic hamster.

Authors:  G Bkaily; A Sculptoreanu; D Jacques; G Jasmin
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

6.  Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts.

Authors:  M L Martínez; M P Heredia; C Delgado
Journal:  J Mol Cell Cardiol       Date:  1999-09       Impact factor: 5.000

7.  T-type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts.

Authors:  L Sen; T W Smith
Journal:  Circ Res       Date:  1994-07       Impact factor: 17.367

8.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

9.  Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro.

Authors:  Toshiaki Izumi; Yasuki Kihara; Nobuaki Sarai; Takeshi Yoneda; Yoshitaka Iwanaga; Koichi Inagaki; Yoko Onozawa; Hiroyuki Takenaka; Toru Kita; Akinori Noma
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

10.  Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.

Authors:  R Schmitt; J P Clozel; N Iberg; F R Bühler
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

View more
  41 in total

1.  A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility.

Authors:  Catherine A Makarewich; Robert N Correll; Hui Gao; Hongyu Zhang; Baohua Yang; Remus M Berretta; Victor Rizzo; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2012-02-02       Impact factor: 17.367

2.  Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling.

Authors:  Federica Accornero; Jop H van Berlo; Robert N Correll; John W Elrod; Michelle A Sargent; Allen York; Joseph E Rabinowitz; Andrew Leask; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

3.  Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy.

Authors:  J Q Kwong; J Davis; C P Baines; M A Sargent; J Karch; X Wang; T Huang; J D Molkentin
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

4.  TRPC channels are necessary mediators of pathologic cardiac hypertrophy.

Authors:  Xu Wu; Petra Eder; Baojun Chang; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

5.  Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.

Authors:  Yogananda S Markandeya; Laura J Phelan; Marites T Woon; Alexis M Keefe; Courtney R Reynolds; Benjamin K August; Timothy A Hacker; David M Roth; Hemal H Patel; Ravi C Balijepalli
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

6.  Microdomain-specific localization of functional ion channels in cardiomyocytes: an emerging concept of local regulation and remodelling.

Authors:  Marina Balycheva; Giuseppe Faggian; Alexey V Glukhov; Julia Gorelik
Journal:  Biophys Rev       Date:  2015-01-15

Review 7.  T-type Ca2+ channels and autoregulation of local blood flow.

Authors:  Lars Jørn Jensen; Morten Schak Nielsen; Max Salomonsson; Charlotte Mehlin Sørensen
Journal:  Channels (Austin)       Date:  2017-01-05       Impact factor: 2.581

8.  Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the Atria.

Authors:  Jerry Curran; Hassan Musa; Crystal F Kline; Michael A Makara; Sean C Little; John D Higgins; Thomas J Hund; Hamid Band; Peter J Mohler
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

9.  Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Authors:  Shin-Shiou Lin; Bing-Hsiean Tzeng; Kuan-Rong Lee; Richard J H Smith; Kevin P Campbell; Chien-Chang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

10.  Adenylyl cyclase 6 deletion increases mortality during sustained β-adrenergic receptor stimulation.

Authors:  Tong Tang; N Chin Lai; Adam T Wright; Mei Hua Gao; Paul Lee; Tracy Guo; Ruoying Tang; Andrew D McCulloch; H Kirk Hammond
Journal:  J Mol Cell Cardiol       Date:  2013-04-12       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.